GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HaTinh Pharmaceutical JSC (HSTC:HDP) » Definitions » Debt-to-EBITDA

HaTinh Pharmaceutical JSC (HSTC:HDP) Debt-to-EBITDA : 0.00 (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is HaTinh Pharmaceutical JSC Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

HaTinh Pharmaceutical JSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. HaTinh Pharmaceutical JSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₫0.00 Mil. HaTinh Pharmaceutical JSC's annualized EBITDA for the quarter that ended in . 20 was ₫0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for HaTinh Pharmaceutical JSC's Debt-to-EBITDA or its related term are showing as below:

HSTC:HDP's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.69
* Ranked among companies with meaningful Debt-to-EBITDA only.

HaTinh Pharmaceutical JSC Debt-to-EBITDA Historical Data

The historical data trend for HaTinh Pharmaceutical JSC's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HaTinh Pharmaceutical JSC Debt-to-EBITDA Chart

HaTinh Pharmaceutical JSC Annual Data
Trend
Debt-to-EBITDA

HaTinh Pharmaceutical JSC Semi-Annual Data
Debt-to-EBITDA

Competitive Comparison of HaTinh Pharmaceutical JSC's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, HaTinh Pharmaceutical JSC's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HaTinh Pharmaceutical JSC's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HaTinh Pharmaceutical JSC's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HaTinh Pharmaceutical JSC's Debt-to-EBITDA falls into.



HaTinh Pharmaceutical JSC Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

HaTinh Pharmaceutical JSC's Debt-to-EBITDA for the fiscal year that ended in . 20 is calculated as

HaTinh Pharmaceutical JSC's annualized Debt-to-EBITDA for the quarter that ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (. 20) EBITDA data.


HaTinh Pharmaceutical JSC  (HSTC:HDP) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


HaTinh Pharmaceutical JSC Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HaTinh Pharmaceutical JSC's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


HaTinh Pharmaceutical JSC (HSTC:HDP) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
167 Ha Huy Tap, Ha Tinh, VNM
HaTinh Pharmaceutical JSC is a pharmaceutical manufacturing and distribution company in Vietnam. Some of its products include Rhomatic Gel, Drafting frame, Hadiphar colon, among others.